Author: News Room
PayPal Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in PayPal between February 25, 2025 and February 2, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against PayPal Holdings, Inc. (“PayPal” or the “Company”) (NASDAQ:…
Dublin, March 04, 2026 (GLOBE NEWSWIRE) — The “Personalized Medicine Biomarkers Market Outlook 2026-2034: Market Share, and Growth Analysis” has been added to ResearchAndMarkets.com’s offering. The Personalized Medicine Biomarkers Market is forecasted to grow from USD 21.52 billion in 2025 to USD 58.25 billion by 2034, reflecting a CAGR of 11.7%. This market forms the backbone of precision healthcare, bridging molecular insights to therapeutic decisions, clinical trials, and disease monitoring. The predominant applications include oncology, with expansion into neurology, cardiometabolic, and autoimmune disease management. Driven by advancements such as next-generation sequencing and AI-driven analytics, the market sees demand from biopharma…
Navan Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in pursuant to and/or traceable to the Company’s Registration Statement and Prospectus (collectively, the “Offering Documents”) issued in connection with the Company’s IPO, on or about October 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP,…
Dublin, March 04, 2026 (GLOBE NEWSWIRE) — The “Non-Alcoholic Steatohepatitis Biomarkers Market Outlook 2026-2034: Market Share, and Growth Analysis” has been added to ResearchAndMarkets.com’s offering. The Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market is poised for significant growth, with an estimated valuation of USD 1.57 billion in 2025, expanding at a CAGR of 24% to reach USD 10.88 billion by 2034. The market includes in-vitro assays, imaging modalities, and algorithmic composites that noninvasively detect steatohepatitis, stage fibrosis, and monitor therapeutic responses across clinical care and drug development. The market encompasses solutions such as routine lab analytes, proprietary serum panels, metabolomic and lipidomic…
Mereo BioPharma Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in Mereo between June 5, 2023 and December 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Mereo BioPharma Group plc (“Mereo” or the…
Kyndryl Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in Kyndryl between August 7, 2024 and February 9, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE:…
Dublin, March 04, 2026 (GLOBE NEWSWIRE) — The “Artificial Intelligence in Stadium Market Outlook 2025-2034: Market Share, and Growth Analysis” has been added to ResearchAndMarkets.com’s offering. The Artificial Intelligence in Stadium Market is poised for substantial growth, with a valuation expected to surge from USD 6.4 billion in 2025 to an impressive USD 155.7 billion by 2034 at a remarkable CAGR of 42.6%. This growth is primarily driven by the escalating demand for enhanced fan experiences and the pressing need for improved stadium security. AI in stadiums revolutionizes fan engagement, security, and operational efficiencies. AI algorithms provide real-time insights by…
Inovio Pharmaceuticals Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in Inovio between October 10, 2023 and December 26, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”)…
Franklin BSP Realty Trust Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in Franklin between November 5, 2024 and February 11, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Franklin BSP Realty Trust, Inc.…
BlackRock Investors With Significant Losses Are Encouraged To Contact Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson To Discuss Their Legal Rights If you purchased or acquired securities in BlackRock TCP between November 6, 2024 and January 23, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BlackRock TCP Capital Corp. (“BlackRock TCP” or…